Overview
Squamous Cell Carcinoma PBMC
Squamous Cell Carcinoma PBMC is collected from IRB-consented donors diagnosed with clinically confirmed Squamous Cell Carcinoma (SCC). These peripheral blood mononuclear cell (PBMC) samples are ideal for analyzing peripheral immune exhaustion and tumor-specific cell subsets. PBMCs are ideal for evaluating immune checkpoint expression, T cell dysfunction, and cellular response to squamous epithelial tumors.
Product Features
- Cryopreserved, clinically verified SCC PBMC samples
- Cryopreserved to ensure stability and long-term storage
- Research Use Only (RUO)
Donor Metadata
- Clinically confirmed SCC diagnosis
- Donor demographics: age, sex assigned at birth, ethnicity
- Medical and treatment history available when applicable
Applications
- Analyzing peripheral immune exhaustion and tumor-specific cell subsets
- Biomarker discovery and validation
- Transcriptomic, proteomic, or functional studies
- Custom assay development and disease modeling
Compliance and Quality
- IRB-approved collection and electronic informed consent
- HIPAA-compliant donor data handling
Ordering and Customization
Squamous Cell Carcinoma PBMC is available in standard and custom volumes. Contact [email protected] for international requests or documentation needs.
Protocols and Documentation
Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.